From: Mutual interaction of lncRNAs and epigenetics: focusing on cancer
lncRNA | Expression level | Target | Cancer | Ref |
---|---|---|---|---|
SNHG14 | Upregulated | EPHA7 | CRC | [138] |
DSCAM-AS1 | Upregulated | miR-216b | Colorectal adenocarcinoma | [139] |
SNHG3 | Upregulated | Med18 | GC | [140] |
LINC00441 | Upregulated | RB1 | GC | [56] |
LINC00337 | Upregulated | TIMP2 | NSCLC | [141] |
MIR210HG | Upregulated | CACNA2D2 | NSCLC | [80] |
H19 | Upregulated | CDH1 | LUAD | [142] |
NEAT1 | Upregulated | CDH1 | OS | [82] |
TNRC6C-AS1 | Upregulated | STK4 | TC | [143] |
LincGALH | Upregulated | Gankyrin | HCC | [84] |
HAGLR | Downregulated | E2F1 | LUAD | [85] |
RMST | Downregulated | DNMT3B | Rhabdomyosarcoma | [144] |
XIST | Upregulated | p53 | Bladder cancer | [145] |
AC016405.3 | Downregulated | TET2 | GBM | [146] |
FENDRR | Downregulated | TET2 | GC | [147] |
MAGI2-AS3 | Downregulated | LRIG1 | AML | [148] |